RAPS.org
|
About RAPS
|
RAPS Store
|
Contact
Guest
| limited access
log in
Join RAPS
Get the Mobile App
|
RF in Your Email
News
Features
Archives
About RF
Advertise
Regulatory Exchange
Departments:
Focus Forward
Under RAPS
In Focus
Quality & Compliance
Science & Technology
Perspective
It's the Law
Focus Online
»
News
News
Search:
Latest News
|
17 May 2012
Committee Calls for Improved Pharmacovigilance, New Labeling Requirements in Europe
2 Likes
The European Parliament’s Environment, Public Health and Food Safety Committee (ENVI) is calling for new methods to monitor, label and withdraw dangerous medicines on an EU-wide basis.Under new
[Read More...]
Tags:
Committee
ENVI
European Parliament
Labeling
Legislation
marketing
Pharmacovigilance
Latest News
|
4 May 2012
EMA Adopts Guidance on Medical Products Containing Genetically Modified Cells
0 Likes
The European Medicines Agency (EMA) announced 5 May it has adopted a scientific guideline on aspects relating to the development and testing of medicinal products containing genetically modified
[Read More...]
Tags:
Cells
CHMP
Clinical Trial
Clinical Trials
EMA
Genetically Modified Cells
GM
GMC
Manufacturing
Non-Clinical Testing
Pharmacovigilance
Postmarketing Studies
Quality
Study
Latest News
|
24 April 2012
FDA Releases Strategic Plan for Veterinary Medicine Program
0 Likes
The US Food and Drug Administration (FDA) has released a new strategic plan for its veterinary medicine program for the 2012-2016 period, outlining the regulatory goals for FDA’s Center for Veterinary
[Read More...]
Tags:
ADE
ANADA
Animal
CVM
FDA
NADA
ORA
Pharmacovigilance
Plan
Strategic
Vet
Veterinary
Latest News
|
5 April 2012
EMA Asks for Feedback on Pharmacovigilance Legislation Implementation
0 Likes
The European Medicines Agency (EMA) is calling on industry to comment on its draft list of European Union reference dates for Period Safety Update Reports (PSURs) that are being implemented as a
[Read More...]
Tags:
EMA
Europe
Legislation
Pharmacovigilance
PSUR
PSURs
Safety
Latest News
|
2 April 2012
EMA Releases Presentations, Videos from Pharmacovigilance Stakeholder Meeting
0 Likes
The European Medicines Agency (EMA) today (2 April) released video and presentations from its fourth stakeholder forum on the implementation of the new pharmacovigilance legislation. The meeting was
[Read More...]
Tags:
Audio
EC
EMA
FMA
IMB
Meeting
MHRA
Pharmacovigilance
Presentations
PV
Video
Latest News
|
26 March 2012
EMA Strengthens Conflict of Interest Policies
0 Likes
The European Medicines Agency (EMA) announced Monday, 26 March its Management Board has endorsed a proposal from EMA Executive Director Guido Rasi to strengthen conflict of interest policies
[Read More...]
Tags:
COI
Conflict of Interest
EMA
Management Board
Pharmacovigilance
Rasi
Latest News
|
1 March 2012
EMA Releases Guideline on Pharmacovigilance Plan Submissions
0 Likes
The European Medicines Agency (EMA) released guidance 29 February on how Marketing Authorization Holders (MAH) can submit pharmacovigilance (PhV) systems as part of their Marketing Authorization
[Read More...]
Tags:
EMA
Guidance
Guideline
MAA
MAH
Pharmacovigilance
PhV
Latest News
|
22 February 2012
EMA to Focus on Pharmacovigilance, Counterfeiting
0 Likes
According to a report by PMLIVE Intelligence Online, the European Medicines Agency (EMA) is setting its sights on new pharmacovigilance laws and fighting counterfeit medicines. The goals are outlined
[Read More...]
Tags:
Counterfeiting
EMA
Pharmacovigilance
Latest News
|
2 February 2012
EMA Prepares for ‘Biggest Change’ to Legal Framework Since Founding
0 Likes
The European Medicines Agency (EMA) announced on 2 February that it “is preparing for the introduction of the new pharmacovigilance legislation in July this year, which will bring the biggest change
[Read More...]
Tags:
Changes
CHMP
EMA
Legislation
Pharmacovigilance
Latest News
|
24 January 2012
EMA Calls for Guidelines on the Use of Pharmacogenomics in Pharmacovigilance Evaluation
0 Likes
The European Medicines Agency (EMA) issued a concept paper on 23 January that calls for a new guideline to be issued on the use of pharmacogenomics in the conduct of pharmacovigilance.The concept
[Read More...]
Tags:
Biomarkers
Clinical Trials
Effectiveness
Efficacy
EMA
Genetics
Pharacogenomics
Pharmacovigilance
Pharmavigilance
Risk
Safety
1
2
Most Viewed
Most Popular
Most Popular
Health Canada, Facing Budget Cuts, Lays off Hundreds of Employees
25 April 2012
New Canadian Regulations Would Dramatically Expand Prescribing Authority
14 May 2012
Study: 510(k) Clearance Down 12% Since 2006, Time for Approval Up 40%
17 January 2012
Regulatory Focus: Week in Review (16-20 April)
20 April 2012
Regulatory Focus: Week in Review (9-13 April)
13 April 2012
Regulatory Focus: Week in Review (26-30 March)
30 March 2012
Regulatory Focus: Week in Review (2-6 April)
6 April 2012
Consumers Union Gears Up To Go After 510(k) Program, Urges MDUFA Markup
20 January 2012
Most Viewed
France: New Agency to Soon Replace AFSSAPS
1 May 2012
Obama Signs Order Promoting International Regulatory Cooperation
1 May 2012
Choosing the Right Regulatory Career: An Inside Look
17 February 2012
FDA Releases Long-Awaited Guidances on Biosimilar Price Competition and Innovation Act
9 February 2012
FDA Provides New Guidance for Promotional Labeling and Advertising
25 January 2012
RAPS Scope of Practice Study: Tracking the Regulatory Profession
22 February 2012
UPDATED: EMA, AFSSAPS Call for Stricter EU Regulations on Medical Devices
6 January 2012
FDA: 99% of Establishment Registrations Now Electronic Post-FDAAA
13 January 2012